India's CRDMO sector is projected to reach US$ 25 billion by 2035, driven by cost advantages, fast project startups, and growing biologics expertise, strengthening its global pharma innovation role.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback